PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) Trial: Rationale and Design

Circulation. Heart failure - United States
doi 10.1161/circheartfailure.112.969071

Related search